Hydreight estimates 2026 revenue of $150-million

Executive Summary

• Hydreight Technologies Inc. issued fiscal 2026 revenue guidance of approximately $150 million, representing a conservative baseline based on currently contracted demand and visible partner activity.
• The company provided a Q1 2026 revenue outlook of $25 million to $28 million, driven by major partnerships and pharmacy product lines going live in late 2025 and early 2026.
• Management expects an adjusted EBITDA margin of 15% to 17% for fiscal 2026, leveraging a largely fixed cost structure to support scaling transaction volumes.

Key Details

• Fiscal 2026 Revenue Guidance: Approximately $150 million.
• Q1 2026 Revenue Outlook: Range of $25 million to $28 million.
• EBITDA Margin Expectation: 15% to 17% adjusted EBITDA margin for fiscal 2026.
• Cost Structure: No material increase in fixed operating costs relative to late 2025 levels; incremental revenue growth supported by existing infrastructure.
• Baseline Assumptions: Guidance is derived solely from existing partner relationships, active customer programs, observable transaction volumes, and contracted demand. It excludes potential contributions from acquisitions, new geographic market entries, or additional enterprise partnerships not currently operational.
• Capital Position: The company recently completed a $15 million bought deal financing led by Canaccord Genuity Corp. to support working capital and anticipated transaction volumes.
• Operational Context: The guidance assumes continued execution across existing pharmacy operations and the digital health platform.

Notable Quotes

• "This guidance reflects the visibility we now have into our operations as we enter 2026. Importantly, it is grounded in existing demand and supported by a disciplined cost structure. With much of our infrastructure already in place, we believe the business is positioned to scale efficiently while maintaining margin discipline as transaction volumes grow." — Shane Madden, Chief Executive Officer